The copper ion itself serves as a cofactor for lysyl oxidase, the enzyme responsible for collagen and elastin cross-linking, meaning GHK-Cu both stimulates production of new structural proteins and ensures they are properly stabilized
By following these steps, healthcare providers can facilitate timely treatment and maximize reimbursement
It is not a hormone, not a steroid, not a stimulant
While animal models and in vitro cultures provided the "proof of concept," the 2026 reclassification has allowed for the validation of these mechanisms in human clinical settings
This content is for informational purposes only
Patients in their 40s and 50s who have never addressed the GHK-Cu decline often present with compounded effects: skin that has thinned significantly, hair that has changed in texture and density over years, and a recovery timeline after procedures that is noticeably longer than it was in their 20s